EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
41 hedge funds and large institutions have $180M invested in Evelo Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
-5
Holders Change %
-10.87%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
10
Reduced
13
Closed
11
Calls
$207K
Puts
$30K
Net Calls
+$177K
Net Calls Change
+$18K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
$6.74M |
2 |
BlackRock
New York
|
$2.52M |
3 |
Geode Capital Management
Boston,
Massachusetts
|
$1.23M |
4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$220K |
5 |
Northern Trust
Chicago,
Illinois
|
$199K |
Top Sellers
1 |
CH
CVI Holdings
Wilmington,
Delaware
|
$3.54M |
2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
$0 |
3 |
Norges Bank
Oslo,
Norway
|
$0 |
4 |
E
Ergoteles
New York
|
$57K |
5 |
EC
EcoR1 Capital
San Francisco,
California
|
$0 |